Exiqon AS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Exiqon AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5324
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exiqon AS (Exiqon), a subsidiary of Qiagen NV, is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company provides product categories such as microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reagent products, among others. It offers microRNA research products such as RNA isolation kits, microRNA sequencing kits, microRNA microarray analysis, universal RT microRNA PCR, microRNA detection probes, ISH detection probes and ISH kits and functional analysis, among others. Exiqon provides services such as RNA isolation services, microRNA PCR service, sequencing, xploreRNA, microRNA ISH services and custom pharma service, among others. The company’s products find applications in isolation, microarray analysis, northern blotting, real-time PCR, in situ hybridization, functional analysis and SNP detection, among others. It operates in Denmark and the US. Exiqon is headquartered in Copenhagen, Denmark.

Exiqon AS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exiqon AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Exiqon AS, Medical Devices Deals, 2012 to YTD 2018 9
Exiqon AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Exiqon AS, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Takara Bio Enters Into Co-Marketing Agreement With Exiqon For miRCURY LNA Products 11
Licensing Agreements 12
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 12
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 13
Transgenomic Expands Licensing Agreement with Exiqon 14
Equity Offering 15
Exiqon Completes Private Placement Of Shares For US$2.6 Million 15
Debt Offering 16
Exiqon Raises USD5.8 Million in Private Placement of 9.25% Note 16
Exiqon Completes Private Placement Of Bonds For US$3 Million 17
Acquisition 18
Qiagen Acquires Exiqon for up to USD102.4 Million 18
Exiqon AS – Key Competitors 20
Exiqon AS – Key Employees 21
Exiqon AS – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Exiqon AS, Pharmaceuticals & Healthcare, Key Facts 2
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exiqon AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exiqon AS, Deals By Therapy Area, 2012 to YTD 2018 8
Exiqon AS, Medical Devices Deals, 2012 to YTD 2018 9
Exiqon AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Takara Bio Enters Into Co-Marketing Agreement With Exiqon For miRCURY LNA Products 11
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 12
Exiqon Enters into Licensing Agreement with Aarhus University Hospital 13
Transgenomic Expands Licensing Agreement with Exiqon 14
Exiqon Completes Private Placement Of Shares For US$2.6 Million 15
Exiqon Raises USD5.8 Million in Private Placement of 9.25% Note 16
Exiqon Completes Private Placement Of Bonds For US$3 Million 17
Qiagen Acquires Exiqon for up to USD102.4 Million 18
Exiqon AS, Key Competitors 20
Exiqon AS, Key Employees 21
Exiqon AS, Subsidiaries 22

List of Figures
Exiqon AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exiqon AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exiqon AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Exiqon AS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Exiqon AS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Southern Power Grid Co Ltd:電力:M&Aディール及び事業提携情報
    Summary China Southern Power Grid Co Ltd (CSG) is a power company that invests in construction, operations and management of the power grids. The company concentrates on developing regional power network, managing power dispatching and transaction center, administering regional power market, and dis …
  • TMX Group Limited (X):企業の財務・戦略的SWOT分析
    TMX Group Limited (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • University of Wisconsin Madison:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Wisconsin Madison (UW-Madison), a subsidiary of University of Wisconsin System is an educational and research institution that provides undergraduate and postgraduate courses. The institution offers courses in various fields such as agricultural and life sciences, arts, busines …
  • Ocado Group Plc:企業の戦略・SWOT・財務分析
    Ocado Group Plc - Strategy, SWOT and Corporate Finance Report Summary Ocado Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Lloyds Banking Group Plc:企業のM&A・事業提携・投資動向
    Lloyds Banking Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lloyds Banking Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • TransAlta Corporation (TA)-エネルギー分野:企業M&A・提携分析
    Summary TransAlta Corporation (TransAlta) is an electricity generation company. It generates electricity from a contracted portfolio of assets using diverse sources such as coal, natural gas, hydro, wind and geothermal. TransAlta's service portfolio comprises commercial and industrial energy service …
  • Quanta Computer Inc (2382):企業の財務・戦略的SWOT分析
    Quanta Computer Inc (2382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Auris Medical Holding Ltd (EARS):企業の財務・戦略的SWOT分析
    Auris Medical Holding Ltd (EARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • AbbVie Inc (ABBV):医療機器:M&Aディール及び事業提携情報
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that develops, manufactures and commercializes advanced therapies for treating complex and serious diseases. It provides pharmaceutical drugs to treat conditions in rheumatology, gastroenterology, dermatology, oncology, virolo …
  • Pharmerica Corp:企業の戦略的SWOT分析
    Pharmerica Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Fremont Petroleum Corp Ltd (FPL):企業の財務・戦略的SWOT分析
    Fremont Petroleum Corp Ltd (FPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Nestle Health Science SA:医療機器:M&Aディール及び事業提携情報
    Summary Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA, is a health science company that manufactures nutritional and medicinal products derived from botanical plants. The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging p …
  • Vitro, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Vitro, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Vitro, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Lepanto Consolidated Mining Company:企業の戦略・SWOT・財務情報
    Lepanto Consolidated Mining Company - Strategy, SWOT and Corporate Finance Report Summary Lepanto Consolidated Mining Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Actelion Ltd:企業の戦略・SWOT・財務分析
    Actelion Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Pacific Gas and Electric Co:企業の戦略的SWOT分析
    Pacific Gas and Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Jamaica Public Service Co Ltd:企業の戦略的SWOT分析
    Jamaica Public Service Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Tourism Holdings Limited:企業の戦略・SWOT・財務分析
    Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • National Mobile Telecommunications Company K.S.C.P.:企業の戦略・SWOT・財務分析
    National Mobile Telecommunications Company K.S.C.P. - Strategy, SWOT and Corporate Finance Report Summary National Mobile Telecommunications Company K.S.C.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's stru …
  • Globo Comunicacao e Participacoes S.A.:企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆